Lixisenatide |
カタログ番号GC31334 |
リキシセナチドは、2 型糖尿病 (T2DM) の治療に使用できるグルカゴン様ペプチド-1 (GLP-1) 受容体アゴニストです。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 320367-13-3
Sample solution is provided at 25 µL, 10mM.
Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM).
[1]. Ahrén B et al. Postprandial Glucagon Reductions Correlate to Reductions in Postprandial Glucose and Glycated Hemoglobin with Lixisenatide Treatment in Type 2 Diabetes Mellitus: A Post Hoc Analysis. Diabetes Ther. 2016 Jun 18 [2]. Lorenz M, et al. Effects of lixisenatide once daily on gastric emptying in type 2 diabetes--relationship to postprandial glycemia. Regul Pept. 2013 Aug 10;185:1-8.
Average Rating: 5
(Based on Reviews and 8 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *